Climate Change Data

Environmental Metrics

ESG Focus Areas

• Development and provision of products useful to society
• Steady supply of high-quality products
• Communication with medical professionals and patients
• Strengthening and enhancement of governance
• Creation of a fulfilling workplace environment
• Environmental initiatives
• Social contribution as a good corporate citizen

Environmental Achievements

• Continued reduction of CO2 emissions
• Maintenance of environmental management systems (acquisition of ISO 14001 certification, etc.)
• Implementation of environment conservation activities (management of chemical substances, etc.)
• Priority purchasing of green products
• Proper management of research and clinical trials that involve genetically modified organisms
• Proper management over purchasing reagents (confirmation of whether reagents fall under the Cartagena Act)

Social Achievements

• Recognition under the 2021 Certified Health & Productivity Management Outstanding Organizations Recognition Program (Large Enterprise Category)
• Initiatives to cultivate the next generation (Platinum Kurumin, etc.)
• Initiatives to promote the success of women
• Prevention of discrimination and harassment
• Recruitment of people with disabilities
• Promotion of work–life balance
• Contribution to culture, the arts, and sports (support in exchange for naming rights, support for activities such as the Seiji Ozawa Matsumoto Festival, and the Matsumoto Yamaga Football Club)
• Participation in local cleanup activities and offering factory and research institute tours
• Donations to child welfare facilities and assistance for natural disasters

Governance Achievements

• Formulation and implementation of the Kissei Basic Policy on Corporate Governance
• Appointment of a female director
• Increase of the number of outside directors
• Creation of a risk management system
• Development and update of business continuity plans to include disaster and pandemic countermeasures
• Implementation of compliance program
• Establishment of a whistle-blowing and consultation system (Kissei Hotline)

Climate Goals & Targets

Environmental Challenges

• Declining birthrate and aging population
• Restrictions on medical and social security costs
• Diversifying medical needs
• Diversifying drug discovery modalities
• Diversifying work styles
• Consideration for the environment
• Revitalizing local communities
• NHI drug pricing system revisions
• Difficulties in predicting drug prices
• Competition with Other Companies’ Products
• Unexpected Side Effects
• Manufacturing and Procurement Malfunctions
• Intellectual Property Rights
• Litigation
• Environmental Conservation
• Information Security Management
• Large-Scale Disasters and Pandemics
• Assets Under Possession
• Recoverability of Deferred Tax Assets

Mitigation Strategies

• Enhancement of business continuity plans
• Formulation of a stable supply manual
• Measures to prevent infection and those for when infection is confirmed
• Creation of a risk management system
• Development and update of business continuity plans to include disaster and pandemic countermeasures
• Implementation of compliance program
• Establishment of a whistle-blowing and consultation system (Kissei Hotline)
• Strengthening corporate governance
• Promoting compliance with laws and regulations
• Continued the stable supply of high-quality products and reduce costs
• Developing personnel for the next generation
• Optimizing cost structure
• Promoting ESG and the SDGs
• Investment in a business promotion system that takes advantage of digital innovation
• Cultivating human resources with the leadership skills to help achieve the goals of the medium-term management plan
• Continued efforts to promote thorough compliance

Supply Chain Management

Responsible Procurement

• Procure environmentally friendly materials

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SDGs, SASB Standards, GRI Standards, Access to Medicine Index

Certifications: ISO 14001, ISO/IEC 27001, ISO 9001

UN Sustainable Development Goals

• SDG 3

Creation and provision of innovative drugs and medical treatment solutions; Improved quality of life for patients and their families; Provision of appropriate drug and treatment-related information; Provision of a motivating workplace and opportunities to develop abilities; Reduction of environmental impact; Contribution to local communities

Awards & Recognition

• 2021 Certified Health & Productivity Management Outstanding Organizations Recognition Program (Large Enterprise Category)
• Platinum Kurumin

Environmental Metrics

ESG Focus Areas

• Environmental
• Social
• Governance

Environmental Achievements

• Reduced CO2 emissions by 19% (Scope 1+2) from 2013 levels by 2022; aiming for 46% reduction by 2030.
• Achieved 74% renewable energy share by 2022 (aiming for 74% by 2030).

Social Achievements

• Launched the PEGASUS project to enhance ESG and SDGs.
• Various initiatives for employee well-being and community investment.

Governance Achievements

• Strengthened ESG governance structure with board and executive oversight.
• Implemented policies for diversity and inclusion.

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to climate events and geopolitical factors.
• Maintaining high quality and safety standards across operations.

Mitigation Strategies

• Developed alternative sourcing strategies.
• Implemented robust quality control and risk management systems.

Supply Chain Management

Responsible Procurement

• Code of conduct
• Supplier sustainability requirements (implied)

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events (implied)

Transition Risks

• Regulatory changes
• Market shifts

Opportunities

• Development of energy-efficient products and services.

Reporting Standards

Frameworks Used: GRI, SASB, TCFD, UN SDGs

Certifications: ISO 14001, ISO 9001, ISO/IEC 27001

UN Sustainable Development Goals

• Various SDGs (implied)

Initiatives contribute to various SDGs through the PEGASUS project.